DGX vs. JNJ
Compare and contrast key facts about Quest Diagnostics Incorporated (DGX) and Johnson & Johnson (JNJ).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: DGX or JNJ.
Correlation
The correlation between DGX and JNJ is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
DGX vs. JNJ - Performance Comparison
Key characteristics
DGX:
0.79
JNJ:
-0.18
DGX:
1.36
JNJ:
-0.16
DGX:
1.16
JNJ:
0.98
DGX:
0.65
JNJ:
-0.16
DGX:
3.01
JNJ:
-0.46
DGX:
5.34%
JNJ:
6.02%
DGX:
20.26%
JNJ:
15.08%
DGX:
-49.46%
JNJ:
-52.60%
DGX:
-6.58%
JNJ:
-15.81%
Fundamentals
DGX:
$17.36B
JNJ:
$352.50B
DGX:
$7.43
JNJ:
$6.06
DGX:
20.93
JNJ:
24.16
DGX:
1.81
JNJ:
0.88
DGX:
$9.54B
JNJ:
$87.70B
DGX:
$3.08B
JNJ:
$60.56B
DGX:
$1.78B
JNJ:
$29.51B
Returns By Period
In the year-to-date period, DGX achieves a 13.43% return, which is significantly higher than JNJ's -4.91% return. Over the past 10 years, DGX has outperformed JNJ with an annualized return of 10.74%, while JNJ has yielded a comparatively lower 6.22% annualized return.
DGX
13.43%
-5.10%
11.32%
14.96%
9.73%
10.74%
JNJ
-4.91%
-4.89%
-1.35%
-3.74%
2.59%
6.22%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
DGX vs. JNJ - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Quest Diagnostics Incorporated (DGX) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
DGX vs. JNJ - Dividend Comparison
DGX's dividend yield for the trailing twelve months is around 1.93%, less than JNJ's 3.40% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DGX Quest Diagnostics Incorporated | 1.93% | 2.02% | 2.08% | 1.40% | 1.85% | 1.99% | 2.34% | 1.83% | 1.72% | 2.07% | 1.92% | 2.24% |
JNJ Johnson & Johnson | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% | 2.64% | 2.83% |
Drawdowns
DGX vs. JNJ - Drawdown Comparison
The maximum DGX drawdown since its inception was -49.46%, smaller than the maximum JNJ drawdown of -52.60%. Use the drawdown chart below to compare losses from any high point for DGX and JNJ. For additional features, visit the drawdowns tool.
Volatility
DGX vs. JNJ - Volatility Comparison
Quest Diagnostics Incorporated (DGX) has a higher volatility of 5.04% compared to Johnson & Johnson (JNJ) at 4.43%. This indicates that DGX's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
DGX vs. JNJ - Financials Comparison
This section allows you to compare key financial metrics between Quest Diagnostics Incorporated and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities